Company Rexahn Pharmaceuticals, Inc. Nyse
Equities
US7616402001
Biotechnology & Medical Research
Business Summary
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 24,813,370 | 23,048,306 ( 92.89 %) | 0 | 92.89 % |
Company contact information
Rexahn Pharmaceuticals, Inc.
15245 Shady Grove Road Suite 455
20850, Rockville
+(248) 957-9024
http://www.rexahn.comSector
1st Jan change | Capi. | |
---|---|---|
-2.31% | 103B | |
+0.56% | 95.28B | |
+1.69% | 22.15B | |
-17.37% | 21.02B | |
-9.30% | 18.15B | |
-41.01% | 16.73B | |
-14.85% | 16.05B | |
+3.21% | 13.68B | |
+33.54% | 12.17B |